This inventor holds 1 USPTO granted patent. Top assignees: Taiwan Liposome Company, Ltd., Tlc Biopharmaceuticals, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 29 
1 out of 32 Years Active: 2014
Title: Innovations of Chi-Chun Lai in Therapeutic Delivery Systems
Introduction
Chi-Chun Lai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of therapeutic delivery systems, particularly in ophthalmology. His innovative work focuses on enhancing the delivery of therapeutic agents to the eyes, which is crucial for treating various eye conditions.
Latest Patents
Chi-Chun Lai holds a patent for a liposome composition designed for the delivery of a therapeutic agent to the eyes. The invention provides a liposome composition that effectively delivers a high payload of a therapeutic agent to neovascularization sites in patients. This liposome composition consists of a particle-forming component made from various vesicle-forming lipids and an agent-carrying component that forms a complex with the therapeutic agent through electrostatic charge-charge interaction or hydrophobic-hydrophobic interaction. The liposome composition has a mean particle diameter of about 30 to 200 nm and can accumulate at the neovascularization sites of the eyes within 24 hours after intravenous administration.
Career Highlights
Throughout his career, Chi-Chun Lai has worked with prominent companies in the biopharmaceutical sector. He has been associated with Taiwan Liposome Company, Ltd. and Tlc Biopharmaceuticals, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Chi-Chun Lai has collaborated with esteemed colleagues, including Jun-Jen Liu and Yun-Long Tseng. These collaborations have fostered a productive environment for innovation and have led to advancements in therapeutic delivery systems.
Conclusion
Chi-Chun Lai's contributions to the field of therapeutic delivery systems, particularly through his patented liposome composition, highlight his role as an influential inventor. His work continues to pave the way for improved treatment options for patients with eye conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile